Skip to main content
. 2023 Feb 28;11(4):178. doi: 10.21037/atm-23-195

Figure 5.

Figure 5

SUCRA. (A) ASAS20; (B) ASAS40; (C) ASAS5/6; (D) BASDAI50; (E) BASFI; (F) AEs. ASAS20, 40: Assessment of SpondyloArthritis International Society 20%, 40% improvement; ASAS5/6: ≥20% improvement in 5 out of 6 the Assessment of SpondyloArthritis International Society domains; BASDAI50: 50% improvement in the Bath Ankylosing Spondylitis Disease Activity Index. SUCRA, surface under the cumulative ranking curve; BASFI, Bath Ankylosing Spondylitis Functional Index; AEs, adverse events; IL, interleukin; TNF-α, tumor-necrosis-factor alpha; JAK, Janus Kinase.